The Karnataka government launched the Bengaluru city logo- making Bengaluru the first Indian city to get its own logo - on 24 December 2017 for branding the city as a
The Pfizer Inc of the United States of America (USA) and its partner BioNTech of Germany completed the phase 3 trial of their COVID-19 vaccine candidate, BNT162b2 against SARS-CoV-2 with 95% effective success rate.